Copyright
©The Author(s) 2020.
World J Exp Med. Apr 27, 2020; 10(3): 26-40
Published online Apr 27, 2020. doi: 10.5493/wjem.v10.i3.26
Published online Apr 27, 2020. doi: 10.5493/wjem.v10.i3.26
Patient demographics | No neoadjuvant chemotherapy, n = 10 | Neoadjuvant chemotherapy, n = 11 | P value |
Age, yr | 49 ± 6 | 49 ± 7 | 1.000 |
Stage of cancer | |||
0 | 2 (9.5) | 0 (0) | 0.2143 |
IA | 6 (28.5) | 2 (9.5) | 0.0805 |
IIA | 1 (5) | 4 (19) | 0.3108 |
IIB | 1 (5) | 2 (9.5) | 1.000 |
IIIA | 0 (0) | 3 (14) | 0.2143 |
Menopausal | 4 (19) | 5 (24) | 1.000 |
Multiparous | 10 (48) | 9 (43) | 0.4762 |
ER+ | 9 (43) | 8 (38) | 0.5865 |
PR+ | 10 (48) | 5 (24) | 0.0124 |
Her2+ | 3 (14) | 6 (28.5) | 0.3870 |
Tobacco | 3 (14) | 1 (5) | 0.3108 |
- Citation: Hagaman AR, Zhang P, Koko KR, Nolan RS, Fromer MW, Gaughan J, Matthews M. Isolation and identification of adipose-derived stromal/stem cells from breast cancer patients after exposure neoadjuvant chemotherapy. World J Exp Med 2020; 10(3): 26-40
- URL: https://www.wjgnet.com/2220-315x/full/v10/i3/26.htm
- DOI: https://dx.doi.org/10.5493/wjem.v10.i3.26